National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/17/2021 release of VAERS data:

This is VAERS ID 1412618



Case Details

VAERS ID: 1412618 (history)  
Form: Version 2.0  
Age: 70.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-06-04
Onset:2021-06-04
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-06-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FA7812 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure increased, Blood pressure measurement, Dizziness, Headache, Palpitations
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Hypertension (narrow), Cardiomyopathy (broad), Vestibular disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: HYPERPHEN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Refractory hypertension
Allergies:
Diagnostic Lab Data: Test Date: 20210604; Test Name: BP; Result Unstructured Data: Test Result:179/80; Test Date: 202106; Test Name: BP; Result Unstructured Data: Test Result:212/80; Test Date: 202106; Test Name: BP; Result Unstructured Data: Test Result:212/79
CDC Split Type: ZAPFIZER INC2021706425

Write-up: Increase in BP over the next few days. Varied from 179/80 to 212/80; Mild headache; Light-headed; racing heart; This is a spontaneous report from a contactable consumer (patient). A 70-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: FA7812), via an unspecified route of administration on 04Jun2021 at 14:16 (at the age of vaccination) as 1st single dose for COVID-19 immunisation. Patient medical history included refractory hypertension. Concomitant medication included hydralazine hydrochloride (HYPERPHEN, tablet, dose: 2 tablets, 20mg) taken for blood pressure (BP). On 04Jun2021, the patient felt lightheaded, mild headache and had a racing heart during the 30 minutes of recovery and patient took lunchtime dose of Hyperphen (2 tablets, 20mg). Hyperphen is one of 4 other BP tablets prescribed (concomitant medication). The patient BP continued to go up to 212/79, increase in bp over the next few days, varied from 179/80 to 212/80. Patient saw her GP (general physician) on Monday 07Jun2021 and GP increased Hyperphen to 3x3 times a day and had increased hypertension medications. It has now gone down considerably. On 04Jun2021, the patient underwent lab tests and procedures which included blood pressure as 179/80 and on an unspecified date in Jun2021, BP was 212/80, and 212/79. Patient received treatment Hyperphen to 3x3 times a day and had increased hypertension medications for event increased BP. Patient informed to note the effect of the Pfizer vaccine on blood pressure. The outcome of event light-headed and racing heart was resolved on an unspecified date in 2021 and rest all events was resolving. No follow-up attempts are needed. No further information is expected.


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1412618


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166